Approvals/TGA/APO-LANSOPRAZOLE ODT lansoprazole 30 mg orally disintegrating tablet blister pack

Approved

STANDARD

APO-LANSOPRAZOLE ODT lansoprazole 30 mg orally disintegrating tablet blister pack

Lupin Australia Pty Limited🇦🇺 Therapeutic Goods Administration

Approval Id: e3512d7218246b5c
Product Name: APO-LANSOPRAZOLE ODT lansoprazole 30 mg orally disintegrating tablet blister pack
Artg Id: 216794
Artg Name: APO-LANSOPRAZOLE ODT lansoprazole 30 mg orally disintegrating tablet blister pack
Sponsor: Lupin Australia Pty Limited
Company Detail Path: /organization/lupin-australia-pty-limited
Artg Date: 2014-11-19
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-CMI-01747-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2015-PI-01607-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

e3512d7218246b5c

Type

Standard